Related Experiment Video
Updated: Jul 11, 2025

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Involvement of microglial P2X7 receptor in pain modulation
Jing Zhang1, Lei Gao1, Yaoyuan Zhang1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Department of Pediatric Dentistry, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Background:
Pain is a rapid response mechanism that compels organisms to retreat from the harmful stimuli and triggers a repair response. Nonetheless, when pain persists for extended periods, it can lead to adverse changes into in the individual's brain, negatively impacting their emotional state and overall quality of life. Microglia, the resident immune cells in the central nervous system (CNS), play a pivotal role in regulating a variety of pain-related disorders. Specifically, recent studies have shed light on the central role that microglial purinergic ligand-gated ion channel 7 receptor (P2X7R) plays in regulating pain. In this respect, the P2X7R on microglial membranes represents a potential therapeutic target.
Aims:
To expound on the intricate link between microglial P2X7R and pain, offering insights into potential avenues for future research.
Methods:
We reviewed 140 literature and summarized the important role of microglial P2X7R in regulating pain, including the structure and function of P2X7R, the relationship between P2X7R and microglial polarization, P2X7R-related signaling pathways, and the effects of P2X7R antagonists on pain regulation.
Results:
P2X7R activation is related to M1 polarization of microglia, while suppressing P2X7R can transfer microglia from M1 into M2 phenotype. And targeting the P2X7R-mediated signaling pathways helps to explore new therapy for pain alleviation. P2X7R antagonists also hold potential for translational and clinical applications in pain management.
Conclusions:
Microglial P2X7R holds promise as a potential novel pharmacological target for clinical treatments due to its distinctive structure, function, and the development of antagonists.
Insights
Microglial purinergic ligand-gated ion channel 7 receptor (P2X7R) plays a key role in chronic pain. Targeting P2X7R offers a promising therapeutic strategy for pain management.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Chronic pain negatively impacts emotional state and quality of life.
- Microglia, the central nervous system's immune cells, are crucial in pain regulation.
- Microglial purinergic ligand-gated ion channel 7 receptor (P2X7R) is a key player in pain disorders.
Purpose of the Study:
- To elucidate the connection between microglial P2X7R and pain.
- To explore P2X7R as a therapeutic target for pain management.
Main Methods:
- Literature review of 140 studies.
- Summarized P2X7R structure, function, and role in microglial polarization.
- Investigated P2X7R signaling pathways and antagonist effects on pain.
Main Results:
- P2X7R activation correlates with M1 microglial polarization; suppression shifts microglia to M2 phenotype.
- Targeting P2X7R-mediated pathways offers new pain alleviation therapies.
- P2X7R antagonists show potential for clinical pain management.
Conclusions:
- Microglial P2X7R is a promising pharmacological target for clinical pain treatment.
- P2X7R's unique structure, function, and available antagonists support its therapeutic potential.
Related Concept Videos
Nociception
Analgesia and Pain Management
Pain
Opioid Receptors: Overview

